GENE gtglabs.com: Prakiraan wutah bathi kanggo taun ngarep
An assessment of the EPS trend for the coming year confirms the resilience of patents and insurance coverage. Profit growth is driven by the expansion of AI diagnostics in clinics and the high margins of consumables. The uniqueness of early cancer detection methodologies allows Genetic Technologies (GENE) to flexibly manage its pricing power. Meanwhile, the 0.00 mark serves as a key metric reflecting the current analyst consensus forecast.
Rincian metrik lan analitis perusahaan Genetic Technologies Limited (GENE)
- rega lan prakiraan konsensus rega:
- data kapitalisasi saham perusahaan:
- indikator kapitalisasi buku:
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal Genetic Technologies|GENE - Kewajiban jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Genetic Technologies Ltd|GENE - Tanggungan utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku Genetic Technologies|GENE - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Genetic Technologies|Indikator likuiditas cepet gtglabs.com
- informasi bathi lan kelipatan valuasi:
GENE - Bathi pungkasan|Bathi mangsa ngarep Genetic Technologies|GENE - Rasio rega pasar marang bathi resik|Pangali Forward P/E Genetic Technologies Ltd|GENE - Rega marang bathi kanthi panyesuaian wutah|Pangali EV/EBITDA Genetic Technologies|GENE - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Genetic Technologies|GENE - Bathi saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan gtglabs.com|GENE - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Genetic Technologies
Pambiji fundamental:Genetic Technologies, GENE
This indicator measures the consensus earnings per share (EPS) growth forecast, allowing investors to filter out market noise and determine the direction of institutional expectations. By analyzing the EPS growth benchmark for Genetic Technologies (GENE) for the coming year, one can assess how the scalability of AI algorithms in mass screening offsets high R&D costs, transforming technological potential into actual financial growth.
Analisis pesaing
Prakiraan wutah bathi resik saben saham kanggo taun ngarep Agilent Tech|Quest Corp (DGX) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep ILMN|exactsciences.com (EXAS) - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep RVTY (Revvity)|Bio-Rad Laboratories, Inc. (BIO) - Prakiraan wutah bathi resik saben saham ing taun ngarep|NNNN - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|SHC (Nordion) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|QDEL: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep opko.com (OPK)|Prakiraan wutah bathi saben saham kanggo taun ngarep CDNA|MRVI (Maravai LifeSciences Holdings) - Proyeksi tambahing bathi saben saham ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep FLGT|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Standard BioTools Corp|Prakiraan wutah bathi kanggo taun ngarep CTKB (Cytek Biosciences, Inc.)|OSUR - Prakiraan wutah bathi saben saham kanggo taun ngarep|XGN: Prakiraan wutah bathi saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep MDXH (MDxHealth S.A.)|LUCD (Lucid Diagnostics Inc) - Prakiraan wutah bathi saben saham kanggo taun ngarep|PRE: Proyeksi tambahing bathi saben saham ing taun ngarep|IMDX (Insight Molecular Diagnostics, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Trinity Biotech Corp TRIB|Prakiraan wutah bathi kanggo taun ngarep PRPH|Prakiraan wutah bathi saben saham kanggo taun ngarep Ainos Inc AIMD|Prakiraan wutah bathi kanggo taun ngarep CODX (Co-Diagnostics Corp)|Dinamika bathi saben saham sing diarepake ing taun ngarep HSCS|BMRA - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|CDIO (Cardio Diagnostics) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Onconetix (ONCO) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Virax Biolabs Group Limited (VRAX)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Bluejay|Prakiraan wutah bathi resik saben saham kanggo taun ngarep AWH|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Accelerate Diagnostics (AXDX)|CNTG - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep ENZ (Enzo Biochem)|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Fresh2 Group Ltd|23andMe Inc. - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Psychemedics Inc PMD
